Viewing StudyNCT00003313



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003313
Status: COMPLETED
Last Update Posted: 2014-11-21
First Post: 1999-11-01

Brief Title: Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Sponsor: Radiation Therapy Oncology Group
Organization: Radiation Therapy Oncology Group

Organization Data

Organization: Radiation Therapy Oncology Group
Class: NETWORK
Study ID: RTOG-9801
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Radiation Therapy Oncology Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
NRG Oncology OTHER
National Cancer Institute NCI NIH